Combined Radiochemotherapy with Paclitaxel in the Treatment of Malignant Glioma
暂无分享,去创建一个
N. Willich | C. Rübe | C. Rübe | A. Schuck | S. Könemann | H. Wassmann | C. Mosler | Marlies Wienstroer | Stefan-Bodo Müller | A. Köhler
[1] A. Nirenberg,et al. Phase II Study of Combination Taxol and Estramustine Phosphate in the Treatment of Recurrent Glioblastoma Multiforme , 2000, Journal of Neuro-Oncology.
[2] K. Walter,et al. Cytotoxicity of taxol in vitro against human and rat malignant brain tumors , 2004, Cancer Chemotherapy and Pharmacology.
[3] A. Siegmann,et al. Acute Toxicity and Changes in Quality of Life during a Combined Radio-Chemotherapy of Glioblastomas with Topotecan (Hycamtin®) , 2001, Strahlentherapie und Onkologie.
[4] P. Herschbach,et al. Krankheitsspezifische Belastungen von Tumorpatienten zu Beginn einer Strahlentherapie Auswirkungen auf den psychosozialen Betreuungsbedarf , 2001, Strahlentherapie und Onkologie.
[5] H. Aydin,et al. Patterns of Failure Following CT-Based 3-D Irradiation for Malignant Glioma , 2001, Strahlentherapie und Onkologie.
[6] M. Hulshof,et al. Prognostic Factors in Glioblastoma Multiforme 10 Years Experience of a Single Institution , 2001, Strahlentherapie und Onkologie.
[7] Gerhard H. Schlund,et al. Anforderungen an die Patientenaufklärung am Beispiel der Strahlentherapie , 2001, Strahlentherapie und Onkologie.
[8] Susan M. Chang,et al. A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants , 2001, Cancer.
[9] H. Dubben,et al. Der Fehler zweiter Art und seine Bedeutung bei der Beurteilung von Resultaten Qualitätsanalyse der Zeitschrift “Strahlentherapie und Onkologie” , 2000, Strahlentherapie und Onkologie.
[10] W. Geerts,et al. The risk of venous thromboembolism is increased throughout the course of malignant glioma , 2000, Cancer.
[11] U. Nestle,et al. A Review of Current and Future Treatment Strategies for Malignant Astrocytomas in Adults , 2000, Strahlentherapie und Onkologie.
[12] L. Beenen,et al. A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] P. Julka,et al. A study of concurrent radiochemotherapy with paclitaxel in glioblastoma multiforme. , 2000, Australasian radiology.
[14] L. Hu,et al. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. , 1997, International journal of radiation oncology, biology, physics.
[15] M. Berger,et al. Phase II study of paclitaxel in patients with recurrent malignant glioma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] H. Choy,et al. Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directions. , 1995, Seminars in Oncology.
[17] M. Chamberlain,et al. Salvage chemotherapy with paclitaxel for recurrent primary brain tumors. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] H. Choy,et al. Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. , 1995, Journal of the National Cancer Institute.
[19] L. Peters,et al. Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. , 1995, Acta oncologica.
[20] M. Taphoorn,et al. Paclitaxel (Taxol) concentrations in brain tumor tissue. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] E. Hall,et al. Taxol and ionizing radiation: interaction and mechanisms. , 1994, International journal of radiation oncology, biology, physics.
[22] E. Hall,et al. Taxol sensitizes human astrocytoma cells to radiation. , 1992, Cancer research.
[23] G. Sheline,et al. Radiotherapy for high grade gliomas. , 1990, International journal of radiation oncology, biology, physics.
[24] S B Green,et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. , 1989, Journal of neurosurgery.
[25] D. Nelson,et al. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. , 1983, International journal of radiation oncology, biology, physics.
[26] Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study. , 1983, European journal of cancer & clinical oncology.
[27] D P Byar,et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.
[28] P. Band,et al. Radiation and high-dose metronidazole in supratentorial glioblastomas. , 1976, The New England journal of medicine.